| Online
abstract submission - Online Abstract
Submission is closed |
|
In order
to download the "Release by author form"
please click »here. |
|
|
| Abstracts must be submitted
on-line via EANO2008 website. |
| Deadline abstract submission:
Extended Deadline Abstract Submission: 11 March
2008. |
| Abstracts sent by mail,
fax or e-mail will NOT be accepted. |
| With the submission of an abstract to EANO VIII,
the presenting author: |
| • |
confirms that all authors are aware of
and agree to the content of the abstract and support the data presented; |
| • |
accepts to be the contact person for all
correspondence about the abstract and inform co-authors about its
status; |
| • |
warrants that the data and conclusions
presented in the abstract have not been published prior to the date
of the EANO VIII conference. Abstracts containing previously published
material will be rejected; |
| • |
states that for studies involving human
or animal subjects, permission has been obtained from the relevant
regulatory authority, and properly informed consent give where appropriate; |
| • |
accepts responsibility for the accuracy
of the submitted abstract; |
| • |
acknowledges that once the abstract is
submitted, changes, corrections or rewording are possible until deadline
of abstract submission (March 11, 2008). |
| • |
confirms that a "Release by author form"
will be completed and returned to the congress office immediately
after receipt of the acceptance of the abstract, else the abstract
cannot be published in an issue of Neuro-Oncology. |
| |
| Careful typing and proof-reading are essential as
the abstract will appear, if accepted, as submitted. |
| |
| Acceptance and selection of abstracts |
|
All submitted abstracts will be reviewed by the Scientific Programme
Committee in March/April 2008, and authors will be notified by email
at the latest begin of June 2008. Abstract selection: Some accepted
abstracts will be selected for oral presentation, some will be presented
as posters.
|
| |
| • |
The abstact must be submitted in good English. |
| • |
The text must not exceed 2500 characters
including spaces, excluding title and authors. |
| • |
A maximum of two institutions per author
is allowed. |
| • |
No more than 10 authors can be listed. |
| • |
No tables, no graphs or illustrations are
allowed. |
| • |
No literature must be cited. |
| |
|
| Please select only ONE topic that refers to the
main subject of your abstract |
|
01. Cell biology and signalling
02. Epidemiology / Quality of life
03. Immunology and immunotherapy
04. In vitro / in vivo models
05. Predictive biomolecular markers
06. New drug delivery methods
07. Neuroimaging of brain tumours
08. Glioblastoma multiforme
09. Anaplastic gliomas
10. Low grade gliomas
11. Pediatric brain tumours
12. Meningiomas
13. Spinal cord tumours
14. Brain and leptomeningeal metastases
15. Neurotoxicity and neuroprotection
16. Paraneoplastic neurological syndromes
17. Supportive care
18. Miscellaneous
|
| |
| Online
abstract submission - Online Abstract
Submission is closed |
|
